<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0360">
 <label>72</label>
 <mixed-citation publication-type="other" id="h0360">InflaRx Announces Decision to Enter Phase III Development of IFX-1 in Severe COVID-19 Induced Pneumonia, 
  <ext-link ext-link-type="uri" xlink:href="https://www.globenewswire.com/news-release/2020/07/21/2064803/0/en/InflaRx-Announces-Decision-to-Enter-Phase-III-Development-of-IFX-1-in-Severe-COVID-19-Induced-Pneumonia.html" id="ir105" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.globenewswire.com/news-release/2020/07/21/2064803/0/en/InflaRx-Announces-Decision-to-Enter-Phase-III-Development-of-IFX-1-in-Severe-COVID-19-Induced-Pneumonia.html</ext-link>. Accessed 21 July 2020.
 </mixed-citation>
</ref>
